European Resuscitation Council Guidelines for Resuscitation 2010 Section 5. Initial management of acute coronary syndromes

Resuscitation

Volumn 81, Issue 10, 2010, Pages 1353-1363

  Arntz, Hans Richard ^a   Bossaert, Leo L ^b   Danchin, Nicolas ^c   Nikolaou, Nikolaos I ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d IASO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTITHROMBIN; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST; FONDAPARINUX; GLYCERYL TRINITRATE; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; MORPHINE; NITRATE; OXYGEN; PLACEBO; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICAGRELOR; TIROFIBAN;

ACUTE CORONARY SYNDROME; ACUTE DISEASE; ACUTE HEART INFARCTION; ADJUVANT THERAPY; ANALGESIC ACTIVITY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHEWABLE TABLET; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; DRUG CHOICE; DRUG DOSAGE FORM COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG SUBSTITUTION; ELECTROCARDIOGRAM; EMERGENCY HEALTH SERVICE; FIBRINOLYSIS; HEALTH CARE QUALITY; HEART INFARCTION; HEART MUSCLE REPERFUSION; HEART SCINTISCANNING; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTERNATIONAL COOPERATION; INVASIVE PROCEDURE; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; LOW DRUG DOSE; LUNG CONGESTION; MEDICAL DECISION MAKING; MEDICAL HISTORY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATION UNIT; OXYGEN THERAPY; PALLIATIVE THERAPY; PATIENT IDENTIFICATION; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROPHYLAXIS; PROVOCATION TEST; REPEAT PROCEDURE; RESUSCITATION; SECONDARY PREVENTION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TACHYCARDIA; THORAX PAIN; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CARDIOVASCULAR AGENTS; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; EUROPE; HUMANS; MYOCARDIAL REPERFUSION; RISK ASSESSMENT; SECONDARY PREVENTION;

EID: 78649446720     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.08.016     Document Type: Article

References (113)

1. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000, 355:688-700.
2. Fox K.A., Cokkinos D.V., Deckers J., Keil U., Maggioni A., Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000, 21:1440-1449.
3. Goodman S.G., Huang W., Yan A.T., et al. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J 2009, 158. 193-201 e1-5.
4. Lowel H., Meisinger C., Heier M., et al. Sex specific trends of sudden cardiac death and acute myocardial infarction: results of the population-based KORA/MONICA-Augsburg register 1985 to 1998. Dtsch Med Wochenschr 2002, 127:2311-2316.
5. Thygesen K., Alpert J.S., White H.D. Universal definition of myocardial infarction. Eur Heart J 2007, 28:2525-2538.
6. Van de Werf F., Bax J., Betriu A., et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008, 29:2909-2945.
7. Antman E.M., Anbe D.T., Armstrong P.W., et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction). Circulation 2004, 110:588-636.
8. Khraim F.M., Carey M.G. Predictors of pre-hospital delay among patients with acute myocardial infarction. Patient Educ Couns 2009, 75:155-161.
9. Douglas P.S., Ginsburg G.S. The evaluation of chest pain in women. N Engl J Med 1996, 334:1311-1315.
10. Solomon C.G., Lee T.H., Cook E.F., et al. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. Am J Cardiol 1989, 63:772-776.
11. Henrikson C.A., Howell E.E., Bush D.E., et al. Chest pain relief by nitroglycerin does not predict active coronary artery disease. Ann Intern Med 2003, 139:979-986.
12. Ioannidis J.P., Salem D., Chew P.W., Lau J. Accuracy and clinical effect of out-of-hospital electrocardiography in the diagnosis of acute cardiac ischemia: a meta-analysis. Ann Emerg Med 2001, 37:461-470.
13. Terkelsen C.J., Lassen J.F., Norgaard B.L., et al. Reduction of treatment delay in patients with ST-elevation myocardial infarction: impact of pre-hospital diagnosis and direct referral to primary percutanous coronary intervention. Eur Heart J 2005, 26:770-777.
14. Brainard A.H., Raynovich W., Tandberg D., Bedrick E.J. The prehospital 12-lead electrocardiogram's effect on time to initiation of reperfusion therapy: a systematic review and meta-analysis of existing literature. Am J Emerg Med 2005, 23:351-356.
15. Swor R., Hegerberg S., McHugh-McNally A., Goldstein M., McEachin C.C. Prehospital 12-lead ECG: efficacy or effectiveness?. Prehosp Emerg Care 2006, 10:374-377.
16. Masoudi F.A., Magid D.J., Vinson D.R., et al. Implications of the failure to identify high-risk electrocardiogram findings for the quality of care of patients with acute myocardial infarction: results of the Emergency Department Quality in Myocardial Infarction (EDQMI) study. Circulation 2006, 114:1565-1571.
17. Feldman J.A., Brinsfield K., Bernard S., White D., Maciejko T. Real-time paramedic compared with blinded physician identification of ST-segment elevation myocardial infarction: results of an observational study. Am J Emerg Med 2005, 23:443-448.
18. Kudenchuk P.J., Ho M.T., Weaver W.D., et al. Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. J Am Coll Cardiol 1991, 17:1486-1491.
19. Dhruva V.N., Abdelhadi S.I., Anis A., et al. ST-segment analysis using wireless technology in acute myocardial infarction (STAT-MI) trial. J Am Coll Cardiol 2007, 50:509-513.
20. Antman E.M., Tanasijevic M.J., Thompson B., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996, 335:1342-1349.
21. Collinson P.O., Gaze D.C., Morris F., Morris B., Price A., Goodacre S. Comparison of biomarker strategies for rapid rule out of myocardial infarction in the emergency department using ACC/ESC diagnostic criteria. Ann Clin Biochem 2006, 43:273-280.
22. Schuchert A., Hamm C., Scholz J., Klimmeck S., Goldmann B., Meinertz T. Prehospital testing for troponin T in patients with suspected acute myocardial infarction. Am Heart J 1999, 138:45-48.
23. Keller T., Zeller T., Peetz D., et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009, 361:868-877.
24. Renaud B., Maison P., Ngako A., et al. Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes. Acad Emerg Med 2008, 15:216-224.
25. Mitchell A.M., Garvey J.L., Kline J.A. Multimarker panel to rule out acute coronary syndromes in low-risk patients. Acad Emerg Med 2006, 13:803-806.
26. Hess E.P., Thiruganasambandamoorthy V., Wells G.A., et al. Diagnostic accuracy of clinical prediction rules to exclude acute coronary syndrome in the emergency department setting: a systematic review. CJEM 2008, 10:373-382.
27. Farkouh M.E., Smars P.A., Reeder G.S., et al. A clinical trial of a chest-pain observation unit for patients with unstable angina. Chest Pain Evaluation in the Emergency Room (CHEER) Investigators. N Engl J Med 1998, 339:1882-1888.
28. Ramakrishna G., Milavetz J.J., Zinsmeister A.R., et al. Effect of exercise treadmill testing and stress imaging on the triage of patients with chest pain: CHEER substudy. Mayo Clin Proc 2005, 80:322-329.
29. Goldstein J.A., Gallagher M.J., O'Neill W.W., Ross M.A., O'Neil B.J., Raff G.L. A randomized controlled trial of multi-slice coronary computed tomography for evaluation of acute chest pain. J Am Coll Cardiol 2007, 49:863-871.
30. Forberg J.L., Hilmersson C.E., Carlsson M., et al. Negative predictive value and potential cost savings of acute nuclear myocardial perfusion imaging in low risk patients with suspected acute coronary syndrome: a prospective single blinded study. BMC Emerg Med 2009, 9:12.
31. Nucifora G., Badano L.P., Sarraf-Zadegan N., et al. Comparison of early dobutamine stress echocardiography and exercise electrocardiographic testing for management of patients presenting to the emergency department with chest pain. Am J Cardiol 2007, 100:1068-1073.
32. Kearney P.M., Baigent C., Godwin J., Halls H., Emberson J.R., Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006, 332:1302-1308.
33. Rawles J.M., Kenmure A.C. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J 1976, 1:1121-1123.
34. Wijesinghe M., Perrin K., Ranchord A., Simmonds M., Weatherall M., Beasley R. Routine use of oxygen in the treatment of myocardial infarction: systematic review. Heart 2009, 95:198-202.
35. Cabello J.B., Burls A., Emparanza J.I., Bayliss S., Quinn T. Oxygen therapy for acute myocardial infarction. Cochrane Database Syst Rev 2010, 6:CD007160.
36. O'Driscoll B.R., Howard L.S., Davison A.G. BTS guideline for emergency oxygen use in adult patients. Thorax 2008, 63:vi1-68.
37. Freimark D., Matetzky S., Leor J., et al. Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol 2002, 89:381-385.
38. Barbash I.M., Freimark D., Gottlieb S., et al. Outcome of myocardial infarction in patients treated with aspirin is enhanced by pre-hospital administration. Cardiology 2002, 98:141-147.
39. Wiviott S.D., Braunwald E., McCabe C.H., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007, 357:2001-2015.
40. Wallentin L., Becker R.C., Budaj A., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2009, 361:1045-1057.
41. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001, 345:494-502.
42. Mehta S.R., Yusuf S., Peters R.J., et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001, 358:527-533.
43. Steinhubl S.R., Berger P.B., Mann J.T., 3rd, et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 2002, 288:2411-2420.
44. Chen Z.M., Jiang L.X., Chen Y.P., et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005, 366:1607-1621.
45. Verheugt F.W., Montalescot G., Sabatine M.S., et al. Prehospital fibrinolysis with dual antiplatelet therapy in ST-elevation acute myocardial infarction: a substudy of the randomized double blind CLARITY-TIMI 28 trial. J Thromb Thrombolysis 2007, 23:173-179.
46. Bosch X., Marrugat J. Platelet glycoprotein IIb/IIIa blockers for percutaneous coronary revascularization, and unstable angina and non-ST-segment elevation myocardial infarction. Cochrane Database Syst Rev 2001, CD002130.
47. Boersma E., Harrington R.A., Moliterno D.J., et al. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet 2002, 359:189-198. [erratum appears in Lancet 2002 June 15;359(9323):2120].
48. Keeley E.C., Boura J.A., Grines C.L. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006, 367:579-588.
49. Stone G.W., Grines C.L., Cox D.A., et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002, 346:957-966.
50. van't Hof A.W., Ernst N., de Boer M.J., et al. Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (on-TIME) trial. Eur Heart J 2004, 25:837-846.
51. Pannu R., Andraws R. Effects of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention after pretreatment with clopidogrel: a meta-analysis of randomized trials. Crit Pathw Cardiol 2008, 7:5-10.
52. De Luca G., Gibson M., Bellandi F., et al. Early glycoprotein IIb-IIIa inhibitors in primary angioplasty (EGYPT) cooperation. An individual patients' data meta-analysis. Heart 2008.
53. TIMI-11B Investigators, Antman E.M., McCabe C.H., et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999, 100:1593-1601.
54. Cohen M., Demers C., Gurfinkel E.P., et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997, 337:447-452.
55. Moscucci M., Fox K.A., Cannon C.P., et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2003, 24:1815-1823.
56. Yusuf S., Mehta S.R., Chrolavicius S., et al. Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 2006, 354:1464-1476.
57. Mehta S.R., Boden W.E., Eikelboom J.W., et al. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. Circulation 2008, 118:2038-2046.
58. Lincoff A.M., Bittl J.A., Harrington R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 2003, 289:853-863.
59. Stone G.W., McLaurin B.T., Cox D.A., et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006, 355:2203-2216.
60. Ferguson J.J., Califf R.M., Antman E.M., et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004, 292:45-54.
61. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 2001, 358:605-613.
62. Eikelboom J.W., Quinlan D.J., Mehta S.R., Turpie A.G., Menown I.B., Yusuf S. Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Circulation 2005, 112:3855-3867.
63. Wallentin L., Goldstein P., Armstrong P.W., et al. Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the assessment of the safety and efficacy of a new thrombolytic regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 2003, 108:135-142.
64. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 2006, 354:1477-1488.
65. Zeymer U., Gitt A., Junger C., et al. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction. Thromb Haemost 2008, 99:150-154.
66. Zeymer U., Gitt A., Zahn R., et al. Efficacy and safety of enoxaparin in combination with and without GP IIb/IIIa inhibitors in unselected patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention. EuroIntervention 2009, 4:524-528.
67. White H.D., Aylward P.E., Frey M.J., et al. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Circulation 1997, 96:2155-2161.
68. Stone G.W., Witzenbichler B., Guagliumi G., et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008, 358:2218-2230.
69. Madsen J.K., Chevalier B., Darius H., et al. Ischaemic events and bleeding in patients undergoing percutaneous coronary intervention with concomitant bivalirudin treatment. EuroIntervention 2008, 3:610-616.
70. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 28:1598-1660.
71. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation 2007, 116:e148-304.
72. Kushner FG, Hand M, Smith SC, Jr., et al., 2009. Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-306. Erratum in: Circulation. 010 March 30;121(12):e257. Dosage error in article text.
73. Boersma E., Maas A.C., Deckers J.W., Simoons M.L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996, 348:771-775.
74. Morrison L.J., Verbeek P.R., McDonald A.C., Sawadsky B.V., Cook D.J. Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 2000, 283:2686-2692.
75. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. The European Myocardial Infarction Project Group. N Engl J Med 1993, 329:383-389.
76. Weaver W.D., Cerqueira M., Hallstrom A.P., et al. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The myocardial infarction triage and intervention trial. JAMA 1993, 270:1211-1216.
77. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group. BMJ 1992, 305:548-553.
78. Welsh R.C., Travers A., Senaratne M., Williams R., Armstrong P.W. Feasibility and applicability of paramedic-based prehospital fibrinolysis in a large North American center. Am Heart J 2006, 152:1007-1014.
79. Pedley D.K., Bissett K., Connolly E.M., et al. Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics. BMJ 2003, 327:22-26.
80. Grijseels E.W., Bouten M.J., Lenderink T., et al. Pre-hospital thrombolytic therapy with either alteplase or streptokinase. Practical applications, complications and long-term results in 529 patients. Eur Heart J 1995, 16:1833-1838.
81. Keeley E.C., Boura J.A., Grines C.L. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003, 361:13-20.
82. Dalby M., Bouzamondo A., Lechat P., Montalescot G. Transfer for primary angioplasty versus immediate thrombolysis in acute myocardial infarction: a meta-analysis. Circulation 2003, 108:1809-1814.
83. Magid D.J., Calonge B.N., Rumsfeld J.S., et al. Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy. JAMA 2000, 284:3131-3138.
84. Steg P.G., Bonnefoy E., Chabaud S., et al. Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation 2003, 108:2851-2856.
85. Bonnefoy E., Steg P.G., Boutitie F., et al. Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J 2009, 30:1598-1606.
86. Kalla K., Christ G., Karnik R., et al. Implementation of guidelines improves the standard of care: the Viennese registry on reperfusion strategies in ST-elevation myocardial infarction (Vienna STEMI registry). Circulation 2006, 113:2398-2405.
87. Pinto D.S., Kirtane A.J., Nallamothu B.K., et al. Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation 2006, 114:2019-2025.
88. Madsen M.M., Busk M., Sondergaard H.M., et al. Does diabetes mellitus abolish the beneficial effect of primary coronary angioplasty on long-term risk of reinfarction after acute ST-segment elevation myocardial infarction compared with fibrinolysis? (A DANAMI-2 substudy). Am J Cardiol 2005, 96:1469-1475.
89. Peterson L.R., Chandra N.C., French W.J., Rogers W.J., Weaver W.D., Tiefenbrunn A.J. Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2). Am J Cardiol 1999, 84:1287-1291.
90. Kereiakes D.J., Gibler W.B., Martin L.H., Pieper K.S., Anderson L.C. Relative importance of emergency medical system transport and the prehospital electrocardiogram on reducing hospital time delay to therapy for acute myocardial infarction: a preliminary report from the Cincinnati Heart Project. Am Heart J 1992, 123:835-840.
91. Le May M.R., So D.Y., Dionne R., et al. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2008, 358:231-240.
92. Gross B.W., Dauterman K.W., Moran M.G., et al. An approach to shorten time to infarct artery patency in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2007, 99:1360-1363.
93. Bradley E.H., Herrin J., Wang Y., et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006, 355:2308-2320.
94. Widimsky P., Groch L., Zelizko M., Aschermann M., Bednar F., Suryapranata H. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000, 21:823-831.
95. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 2006, 367:569-578.
96. Herrmann H.C., Lu J., Brodie B.R., et al. Benefit of facilitated percutaneous coronary intervention in high-risk ST-segment elevation myocardial infarction patients presenting to nonpercutaneous coronary intervention hospitals. JACC Cardiovasc Interv 2009, 2:917-924.
97. Gershlick A.H., Stephens-Lloyd A., Hughes S., et al. Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction. N Engl J Med 2005, 353:2758-2768.
98. Danchin N., Coste P., Ferrieres J., et al. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation 2008, 118:268-276.
99. Cantor W.J., Fitchett D., Borgundvaag B., et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009, 360:2705-2718.
100. Hochman J.S., Sleeper L.A., Webb J.G., et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999, 341:625-634.
101. Arntz H.R., Wenzel V., Dissmann R., Marschalk A., Breckwoldt J., Muller D. Out-of-hospital thrombolysis during cardiopulmonary resuscitation in patients with high likelihood of ST-elevation myocardial infarction. Resuscitation 2008, 76:180-184.
102. Garot P., Lefevre T., Eltchaninoff H., et al. Six-month outcome of emergency percutaneous coronary intervention in resuscitated patients after cardiac arrest complicating ST-elevation myocardial infarction. Circulation 2007, 115:1354-1362.
103. Spaulding C.M., Joly L.M., Rosenberg A., et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med 1997, 336:1629-1633.
104. Sunde K., Pytte M., Jacobsen D., et al. Implementation of a standardised treatment protocol for post resuscitation care after out-of-hospital cardiac arrest. Resuscitation 2007, 73:29-39.
105. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985, 27:335-371.
106. Chen Z.M., Pan H.C., Chen Y.P., et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005, 366:1622-1632.
107. Teo K.K., Yusuf S., Furberg C.D. Effects of prophylactic antiarrhythmic drug therapy in acute myocardial infarction. An overview of results from randomized controlled trials. JAMA 1993, 270:1589-1595.
108. Hine L.K., Laird N., Hewitt P., Chalmers T.C. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Arch Intern Med 1989, 149:2694-2698.
109. Swedberg K., Held P., Kjekshus J., Rasmussen K., Ryden L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992, 327:678-684.
110. Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. Circulation 1998, 97:2202-2212.
111. Patti G., Pasceri V., Colonna G., et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007, 49:1272-1278.
112. Hulten E., Jackson J.L., Douglas K., George S., Villines T.C. The effect of early, intensive statin therapy on acute coronary syndrome: a meta-analysis of randomized controlled trials. Arch Intern Med 2006, 166:1814-1821.
113. Heeschen C., Hamm C.W., Laufs U., Snapinn S., Bohm M., White H.D. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation 2002, 105:1446-1452.